Clinical Trial Update: Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of a quadruple regimen (pioglitazone, atorvastatin, pegylated interferon alfa-2a, and ribavirin) in genotype 1 he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Actos (Pioglitazone)
• Lipitor (atorvastatin)
• Pegasys (pegylated interferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Brooke Army Medical Center | Conditions: Hepatitis c | Phase 4 | Status: COMPLETED